Biodel expands ongoing Phase III VIAject clinical trials into Europe (BIOD) 18.34 -0.30 : BIOD announced that the co has expanded its two ongoing pivotal Phase III clinical trials of VIAject into Europe. Clinical sites have been initiated in Germany and patient treatment has begun.